Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$491M |
| 2 |
Microsoft
MSFT
|
+$352M |
| 3 |
Apple
AAPL
|
+$346M |
| 4 |
Janus Henderson Mortgage-Backed Securities ETF
JMBS
|
+$333M |
| 5 |
Cisco
CSCO
|
+$324M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Novartis
NVS
|
+$409M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$374M |
| 3 |
State Street SPDR Portfolio Short Term Corporate Bond ETF
SPSB
|
+$347M |
| 4 |
ATVI
Activision Blizzard
ATVI
|
+$343M |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$334M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.03% |
| 2 | Financials | 12.41% |
| 3 | Healthcare | 11.8% |
| 4 | Consumer Discretionary | 10.03% |
| 5 | Industrials | 9.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Citigroup
C
$227B
| $728M | 0.18% |
14,146,772
+395,571
| +3% | +$17.5M |
|
102
Booking.com
BKNG
$160B
| $722M | 0.18% |
5,086,350
-18,200
| -0.4% | -$2.27M |
|
103
Elevance Health
ELV
$86.2B
| $721M | 0.18% |
1,528,855
+50,701
| +3% | +$23.4M |
|
104
Lowe's Companies
LOW
$123B
| $715M | 0.18% |
3,211,131
+41,451
| +1% | +$8.4M |
|
105
American Express
AXP
$229B
| $713M | 0.18% |
3,839,276
+667,695
| +21% | +$107M |
|
106
Intuitive Surgical
ISRG
$139B
| $706M | 0.18% |
2,094,141
+63,726
| +3% | +$19M |
|
107
Truist Financial
TFC
$63.4B
| $691M | 0.18% |
19,238,388
+1,458,248
| +8% | +$45.8M |
|
108
JPMorgan Ultra-Short Income ETF
JPST
$40.6B
| $676M | 0.17% |
13,457,071
+3,081,352
| +30% | +$155M |
|
109
NextEra Energy
NEE
$177B
| $655M | 0.17% |
10,782,674
+429,979
| +4% | +$24.5M |
|
110
Zoetis
ZTS
$30.9B
| $651M | 0.17% |
3,322,271
+7,138
| +0.2% | +$1.26M |
|
111
Uber
UBER
$159B
| $631M | 0.16% |
10,256,352
+4,402,382
| +75% | +$230M |
|
112
Deere & Co
DE
$164B
| $628M | 0.16% |
1,570,773
+31,074
| +2% | +$11.7M |
|
113
Crown Castle
CCI
$31.3B
| $626M | 0.16% |
5,478,477
+122,948
| +2% | +$12.6M |
|
114
Vertex Pharmaceuticals
VRTX
$133B
| $614M | 0.16% |
1,509,206
+41,778
| +3% | +$15.4M |
|
115
TJX Companies
TJX
$175B
| $613M | 0.16% |
6,534,165
+115,304
| +2% | +$10.3M |
|
116
Lam Research
LRCX
$383B
| $609M | 0.15% |
7,777,220
+149,020
| +2% | +$10.2M |
|
117
Cigna
CI
$73.6B
| $592M | 0.15% |
1,978,465
+53,414
| +3% | +$15.6M |
|
118
Gilead Sciences
GILD
$165B
| $590M | 0.15% |
7,281,489
+87,482
| +1% | +$6.81M |
|
119
Bristol-Myers Squibb
BMY
$132B
| $583M | 0.15% |
11,361,717
+134,815
| +1% | +$7.08M |
|
120
Huntington Bancshares
HBAN
$35.6B
| $574M | 0.15% |
45,848,079
+103,798
| +0.2% | +$1.14M |
|
121
Progressive
PGR
$124B
| $559M | 0.14% |
3,509,705
+146,130
| +4% | +$22.9M |
|
122
Micron Technology
MU
$972B
| $550M | 0.14% |
6,450,347
+120,406
| +2% | +$8.94M |
|
123
Regeneron Pharmaceuticals
REGN
$83.2B
| $545M | 0.14% |
620,616
+22,558
| +4% | +$18.6M |
|
124
LyondellBasell Industries
LYB
$20.2B
| $540M | 0.14% |
5,683,892
+33,212
| +0.6% | +$3.11M |
|
125
Mondelez International
MDLZ
$78.5B
| $536M | 0.14% |
7,399,451
+127,904
| +2% | +$8.76M |
|
Similar funds
Charles Schwab's Q4 2023 Portfolio in Review
As of Q4 2023, Charles Schwab held 3,619 positions worth $394B, up 13% from $349B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Trading was light in Q4 2023: portfolio turnover was 3.5%. Charles Schwab opened 44 new positions and exited 81, leaving the 3,619-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q4 2023 buy was Janus Henderson Mortgage-Backed Securities ETF: 7,612,323 shares worth $350M.
- Charles Schwab added most to Merck in Q4 2023, an estimated $491M increase.
- Charles Schwab's biggest Q4 2023 reduction was Novartis, cutting an estimated $409M.
- Charles Schwab fully exited Activision Blizzard in Q4 2023, selling an estimated $343M.
- Charles Schwab's ten largest holdings make up 19% of its $394B portfolio in Q4 2023.
- Charles Schwab opened 44 new positions and closed 81 in Q4 2023.
- Charles Schwab's portfolio value rose 13% quarter-over-quarter to $394B.
Based on Charles Schwab's 13F filing for Q4 2023, filed 6 Feb 2024.